Ottawa Hospital Research Institute: Infections trials

The registry lists 10 Infections studies with Ottawa Hospital Research Institute as lead sponsor. 2 are open to participants now and 3 have results posted.

Phase 1 2Phase 2 1Phase 3 2Phase 4 2No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Naproxen Versus Placebo as Adjunct Treatment of CellulitisNot yet recruitingNCT07665476Phase 3
• Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV InfectionRecruitingNCT03147859Phase 2
• Assessing the Mother-to-infant Transmission Capabilities of COVID-19 Infection Among Pregnant Women in Ontario, CanadaCompletedNCT04913948Results posted
• A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of MaravirocCompletedNCT01894776Phase 1Results posted
• Quinolone Prophylaxis for the Prevention of BK Virus Infection in Kidney Transplantation: A Pilot StudyCompletedNCT01353339Phase 4Results posted
• Use of Phage Therapy for Treatment of a Periprosthetic Joint InfectionActive, not recruitingNCT06827041Phase 1
• Trial Investigating Cyanoacrylate Glue to Prevent Surgical Site Infection Following Breast SurgeryStatus unknownNCT02779296Phase 4
• Impact of Chronic Statin Use During Surgery on Inflammation and Infection RatesCompletedNCT00967252
• Micronutrients and Antioxidants in HIV InfectionCompletedNCT00798772Not applicable
• A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infectionWithdrawnNCT00414414Phase 3